Andrew Satz, MSc

Andrew Satz is the founder and CEO of EVQLV, a technology company accelerating antibody design and development. A data scientist by training, Andrew is a passionate technologist and innovator with nearly two decades in applied artificial intelligence. He has founded or led technology companies across multiple industries, including biotech, where he helped bring 3 drugs from discovery to IND. He co-developed EVQLV's antibody discovery engine, which uses a wide range of machine learning and software engineering techniques to scale and speed the design and screening of therapeutic antibodies.